Literature DB >> 28228298

Re chronic stable angina guidelines.

Prabha Nini Gupta1, Praveen Velappan2, Krishna Kumar Bhaskara Pillai2, Riyas Abdul Salam2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28228298      PMCID: PMC5319125          DOI: 10.1016/j.ihj.2017.01.004

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


× No keyword cloud information.
Dear Dr Mishra, I read with interest your new guidelines on Chronic stable angina. I feel one or two things should be added the guidelines. The type of chest pain is very important. Just as the ACC guidelines say a chest pain that worsens on emotion or exertion and is relieved at rest is likely to be a cardiac pain. This should be emphasized. The duration of the chest pain is also important. We should emphasize a 1 or 2 s chest pain localized with a finger tip is not a cardiac pain. The second point is – any new onset angina should be treated with loading with clopidogrel as it acts within 2 h and reduces cardiovascular mortality. So we should include clopidogrel in the guidelines. When clopidogrel is given as 75 mg daily it takes 5–7 days to achieve optimum platelet inhibition. Both the Cure trial and the PCI-Cure trials have shown that clopidogrel reduces the total cardiovascular mortality significantly.5, 6 Statins like atorvastatin should be given at the 40 mg dose. In STEMI patients loading with statin 80 mg atorvastatin and continuing 40 mg statin(atorvastatin) has been shown to reduce the following inflammatory markers-high sensitivity CRP,BNP and MMP 9 high-sensitivity C-reactive protein (hs-CRP), B-type natriuretic peptide (BNP), and matrix metalloproteinase type 9 (MMP-9) (P < 0.05). The ejection fraction of these patients also increased better than in those given low dose statins. I feel stenting for simple left main coronary artery disease is better than CABG because there is no time delay (Fig. 1, Fig. 2, Fig. 3, Fig. 4, Fig. 5, Fig. 6). I find left main patients sometimes die even before they can go for surgery. So I feel if they have a low syntax score,in India we should recommend early PCI even as a class 1 indication.
Fig. 1

The coronary angiogram of a patient with chronic stable angina. Her age was 47 years. (Proximal left main stenosis of 80%).

Fig. 2

Another angiographic view of the same patient.

Fig. 3

Her electrocardiogram before angiogram.

Fig. 4

Her electrocardiogram 4 h after angiogram showing multiple ST depressions.

Fig. 5

Her angiogram after intervention,she was stented with a 4 × 23 Science Prime stent,Post dilatation was done and ostial flaring was also done.

Fig. 6

The stent seen after intervention.

We have had numerous patients who survived after left main stenting and did not have repeat events. I would like to show the electrocardiograms and angiographic pictures of one such patient (Fig. 1, Fig. 2, Fig. 3, Fig. 4). She had chronic stable angina .She became unstable after 4 h after the angiogram and the stenting was done at ll pm and finished at 1 am (Fig. 5, Fig. 6). She survived and still comes for follow-up. She did not have adequate finances to send for emergency CABG. Other wise the guideline is quite adequate. Thanking you,
  6 in total

1.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

2.  The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.

Authors:  S R Mehta; S Yusuf
Journal:  Eur Heart J       Date:  2000-12       Impact factor: 29.983

3.  Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects.

Authors:  M Savcic; J Hauert; F Bachmann; P J Wyld; B Geudelin; R Cariou
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

4.  Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.

Authors:  Hui-liang Liu; Yong Yang; Sheng-li Yang; Jian-ping Luo; Hong Li; Li-min Jing; Zhi-qi Shen
Journal:  Clin Ther       Date:  2013-02-12       Impact factor: 3.393

5.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

Authors:  S R Mehta; S Yusuf; R J Peters; M E Bertrand; B S Lewis; M K Natarajan; K Malmberg; H Rupprecht; F Zhao; S Chrolavicius; I Copland; K A Fox
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

Review 6.  Management standards for stable coronary artery disease in India.

Authors:  Sundeep Mishra; Saumitra Ray; Jamshed J Dalal; J P S Sawhney; S Ramakrishnan; Tiny Nair; S S Iyengar; V K Bahl
Journal:  Indian Heart J       Date:  2016-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.